GGrantIndex
Sort

46,585 grants matching heart failure

Linkage of Alcohol Abusers to Primary Care

$861,720
Richard Saitz · Boston Medical Center · R01 · FY2008 · AA

Counseling older Americans to control hypertension (COACH)

$861,713
Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2010 · MD

The health status of Caucasian and African American living with kidney donors

$861,615
Sandra J Taler · Mayo Clinic Rochester · U01 · FY2010 · AI

Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide

$861,551
Alexander A Shishkin · Eclipse Bioinnovations Inc · R44 · FY2022 · HG

Cholesterol reduction and cardiovascular risk in Type 1 diabetes

$861,449
Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2022 · HL

Impact of Infection and Inflammation on Primitive Hematopoiesis

$861,418
Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2025 · HL

Impact of Infection and Inflammation on Primitive Hematopoiesis

$861,418
Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2023 · HL

True 4DCT for Quantifying LV Dyssynchrony and Function for Targeting LV Lead Location in CRT

$861,323
Elliot R McVeigh · University Of California, San Diego · R01 · FY2020 · HL

Mechanisms underlying the blood pressure lowering effect of sleep extension.

$861,021
Janet M Mullington · Beth Israel Deaconess Medical Center · R01 · FY2017 · HL

Clinical effectiveness of a wearable hydration device

$860,515
Eamon Johnson · Tritonx Inc. · R42 · FY2025 · AG

Understanding Long-term Outcomes of Living Kidney Donors using Real-World Evidence from National EHR Data

$860,513
Michal A Mankowski · New York University School Of Medicine · R01 · FY2025 · DK

Live-Cell Fluorescence Lifetime FRET Assays for HTS

$860,487
Gregory David Gillispie · Fluorescence Innovations, Inc. · R42 · FY2015 · DA

A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.

$860,397
Kaustubh Kale · Aventusoft, Llc · R44 · FY2025 · HL

True 4DCT for Quantifying LV Dyssynchrony and Function for Targeting LV Lead Location in CRT

$860,388
Elliot R McVeigh · University Of California, San Diego · R01 · FY2021 · HL

Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis

$860,262
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL

Development of protein therapeutic for acute kidney injury

$860,143
Tao Tan · Trim-Edicine, Inc. · R44 · FY2017 · DK

Depression and Heart Failure Disease Progression

$860,073
Andrew Sherwood · Duke University · R01 · FY2017 · HL

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

$860,001
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2018 · HL

The Look AHEAD Continuation: Action for Health in Diabetes

$859,981
Helen Pauline Hazuda · University Of Texas Hlth Science Center · U01 · FY2009 · DK

Deep mutational scanning of MYH7 in genome-edited cardiomyocytes

$859,932
Kai-Chun Daniel Yang · University Of Washington · R01 · FY2024 · HL

Studies in pig-to-primate cardiac xenotransplantation

$859,867
Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2007 · AI

PROVEN: PRagmatic trial Of Video Education in Nursing homes

$859,863
Vincent Mor · Brown University · UH2 · FY2014 · AG

The Synthesis and Preclinical Studies of New Treatments for Neurodegenerative Dis

$859,654
Carol E Green · Sri International · N01 · FY2011 · AG

Cardiorenal Genomics for Risk Prediction in African Descent Populations

$859,443
Marguerite R Irvin · University Of Alabama At Birmingham · R35 · FY2021 · HL

A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients with Acute Heart Failure

$859,309
Sean Patrick Collins · Vanderbilt University Medical Center · R33 · FY2022 · HL